Multiple Endocrine Neoplasia – Introduction

Each multiple endocrine neoplasia (MEN) syndrome expresses striking features of hormone oversecretion from its own characteristic group of tissues. Additional expressions include non‐hormonal tumours in each MEN syndrome and selected cancers in some syndromes. The complexity of its stereotyped features results in difficult management issues that often justify cooperation across multiple specialties. MEN syndromes, though rare, have long received intense study as models for more common diseases. The syndromal nature often with a large pedigree has promoted recent discovery of the main gene that differs for each of the six MEN syndromes. Each mutant gene has been introduced into clinical decision‐making and into further clarification of tumorigenesis. This mini‐symposium is related to the 9th International Workshop on Multiple Endocrine Neoplasia in June 2004; it consists of six manuscripts. They report new developments in clinical practices and in basic understandings about this rapidly advancing field.

[1]  R. Thakker,et al.  The hyperparathyroidism-jaw tumour (HPT-JT) syndrome , 2006 .

[2]  T. Carling,et al.  Parathyroid surgery in familial hyperparathyroid disorders * , 2005, Journal of internal medicine.

[3]  M. Brandi,et al.  Surgery for gastroenteropancreatic tumours in multiple endocrine neoplasia type 1: review and personal experience , 2005, Journal of internal medicine.

[4]  I. Ilias,et al.  Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour , 2005, Journal of internal medicine.

[5]  M. Rubin,et al.  Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features , 2005, Journal of internal medicine.

[6]  H. Dralle,et al.  Advances in the management of hereditary medullary thyroid cancer , 2005, Journal of internal medicine.

[7]  R. B. van der Luijt,et al.  Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines , 2005, Journal of internal medicine.

[8]  J. Carpten,et al.  Uterine tumours are a phenotypic manifestation of the hyperparathyroidism‐jaw tumour syndrome , 2005, Journal of internal medicine.

[9]  C. Stratakis,et al.  Down-Regulation of Regulatory Subunit Type 1A of Protein Kinase A Leads to Endocrine and Other Tumors , 2004, Cancer Research.

[10]  E. Arteaga,et al.  Novel intronic mutation of MEN1 gene causing familial isolated primary hyperparathyroidism. , 2004, Journal of Clinical Endocrinology and Metabolism.

[11]  L. Johnson,et al.  Protein Kinase Inhibitors: Insights into Drug Design from Structure , 2004, Science.

[12]  A. Knudson,et al.  Two genetic hits (more or less) to cancer , 2001, Nature Reviews Cancer.

[13]  S. Marx Clinical review 109: Contrasting paradigms for hereditary hyperfunction of endocrine cells. , 1999, Journal of Clinical Endocrinology and Metabolism.

[14]  P. Wermer Genetic aspects of adenomatosis of endocrine glands. , 1954, The American journal of medicine.